In a first for the NHS, an immunotherapy drug is now available to delay the onset of type 1 diabetes. According to BBC News, the treatment can give patients up to three extra years before they require insulin therapy. The drug is available to both children and adults, offering a significant advance in managing this lifelong condition.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton